cnbc.com / .cnbc-com-health-care / Page 5

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company announced a cost-cutting plan.

Samsung's smart ring debut put the products firmly in the spotlight, with one analyst predicting that Apple could launch its own smart ring in 2026.

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here's how Americans voted on abortion access.

Trump could further restrict or effectively ban abortion on the federal level through methods that won't require Congress to pass new legislation.

The FDA said the proposed order is not final yet, which means companies can still market over-the-counter drugs containing oral phenylephrine for now.

Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023.

CVS expects elevated medical costs to continue to pressure its performance this year, "and as a result we are not providing a formal outlook at this time."

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance.

Some health experts say Kennedy, even in an informal role, could potentially lead to real consequences for patients, drugmakers and the nation's public health.

Donald Trump said Robert F. Kennedy Jr.'s proposal to remove fluoride from the U.S. water systems "sounds okay" to him, raising alarms for public health.